The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma

Chest

Volumn 147, Issue 2, 2015, Pages 397-405

  Brannan, John D ^a   Bood, Johan ^b,c   Alkhabaz, Ahmad ^a   Balgoma, David ^b   Otis, Joceline ^d   Delin, Ingrid ^b   Dahlén, Barbro ^b,c   Wheelock, Craig E ^b   Nair, Parameswaran ^a   Dahlén, Sven Erik ^b   O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYEICOSAPENTAENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYEICOSAPENTAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; CORTICOSTEROID; DOCOSAHEXAENOIC ACID; DRUG METABOLITE; ICOSAPENTAENOIC ACID; LEUKOTRIENE E4; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN D2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; MANNITOL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BRONCHIAL HYPERRESPONSIVENESS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL COUNT; EOSINOPHILIA; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MAST CELL; MEDICATION COMPLIANCE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; SPIROMETRY; SPUTUM ANALYSIS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; YOUNG ADULT; BLOOD; BRONCHIAL HYPERREACTIVITY; CYTOLOGY; DOSE RESPONSE; EOSINOPHIL; LEUKOCYTE COUNT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPUTUM;

ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EOSINOPHILIA; EOSINOPHILS; FATTY ACIDS, OMEGA-3; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; MANNITOL; MAST CELLS; SPUTUM; TRIGLYCERIDES; YOUNG ADULT;

EID: 84928349537     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1214     Document Type: Article

References (30)

1. Reisman J, Schachter HM, Dales RE, et al. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med. 2006; 6: 26.
2. Arm JP, Horton CE, Mencia-Huerta JM, et al. Eff ect of dietary supplementation with fi sh oil lipids on mild asthma. Th orax. 1988; 43 ( 2): 84-92.
3. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH. The eff ects of dietary supplementation with fi sh oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis. 1989; 139 ( 6): 1395-1400.
4. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003; 168 ( 10): 1181-1189.
5. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective eff ect of fi sh oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006; 129 ( 1): 39-49.
6. Tecklenburg-Lund S, Mickleborough TD, Turner LA, Fly AD, Stager JM, Montgomery GS. Randomized controlled trial of fish oil and montelukast and their combination on airway infl ammation and hyperpnea-induced bronchoconstriction P LoS One. 2010; 5 ( 10): e13487.
7. Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise-and hyperventilation-induced asthma. Am J Respir Crit Care Med. 1998; 158 ( 4): 1120-1126.
8. Anderson SD. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. Treat Respir Med. 2004; 3 ( 6): 365-379.
9. Brannan JD, Anderson SD, Freed R, Leuppi JD, Koskela H, Chan HK. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am J Respir Crit Care Med. 2000; 161 ( 6): 2096-2099.
10. Brannan JD, Anderson SD, Gomes K, King GG, Chan HK, Seale JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol Am J Respir Crit Care Med. 2001; 163 ( 6): 1420-1425.
11. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J. 2006; 27 ( 5): 944-950.
12. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is. J Allergy Clin Immunol. 2000; 106 ( 3): 453-459.
13. O'Sullivan S, Roquet A, Dahlén B, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J. 1998; 12 ( 2): 345-350.
14. Kippelen P, Larsson J, Anderson SD, et al. Acute eff ects of beclomethasone on hyperpnea-induced bronchoconstriction. Med Sci Sports Exerc. 2010; 42 ( 2): 273-280.
15. Holzer K, Anderson SD, Chan HK, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003; 167 ( 4): 534-537.
16. Balgoma D, Larsson J, Rokach J, et al. Quantifi cation of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: controlling matrix eff ects. A nal Chem. 2013; 85 ( 16): 7866-7874.
17. Brannan JD, Koskela H, Anderson SD, Chan HK. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology. 2002; 7 ( 1): 37-44.
18. Mickleborough TD, Vaughn CL, Shei RJ, Davis EM, Wilhite DP. Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Respir Med. 2013; 107 ( 8): 1152-1163.
19. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release aft er mannitol inhalation. Eur Respir J. 2003; 22 ( 3): 491-496.
20. Kippelen P, Larsson J, Anderson SD, Brannan JD, Dahlén B, Dahlén SE. Eff ect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc. 2010; 42 ( 10): 1853-1860.
21. Th ien FC, Mencia-Huerta JM, Lee TH. Dietary fi sh oil eff ects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis. 1993; 147 ( 5): 1138-1143.
22. Schuster GU, Bratt JM, Jiang X, et al. Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary infl ammation in mice. Am J Respir Cell Mol Biol. 2014; 50 ( 3): 626-636.
23. Melillo E, Woolley KL, Manning PJ, Watson RM, O'Byrne PM. Eff ect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med. 1994; 149 ( 5): 1138-1141.
24. Picado C, Castillo JA, Schinca N, et al. Eff ects of a fi sh oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. Th orax. 1988; 43 ( 2): 93-97.
25. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2007; 77 ( 5-6): 327-335.
26. Dahlén SE, Hedqvist P, Hammarström S. Contractile activities of several cysteinecontaining leukotrienes in the guinea-pig lung strip. Eur J Pharmacol. 1982; 86 ( 2): 207-215.
27. Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. Prostaglandins. A nnu Rev Biochem. 1975; 44: 669-695.
28. Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem. 1997; 272 ( 27): 16709-16712.
29. Subbarao P, Duong M, Adelroth E, et al. Eff ect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol. 2006; 117 ( 5): 1008-1013.
30. Turton JA, Glasgow NJ, Brannan JD. Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study. Prim Care Respir J. 2012; 21 ( 1): 28-34.